Revance Therapeutics Inc (RVNC)

[AXRX4952]

base pay is a lower now so it's a lot of younger reps who are hungry to get into "aesthetics" any way they can. Not many are left from the initial hire in 2020 when RHA first launched and the sales force became active. Comp plan changes quarterly and most tenured reps will not put up with the goal post moving every 90 days. RVNC sales force has been through the ringer from Covid shut downs, to the Daxi CRL delay of 1 year and then a failed launch of Daxi. They all came to sell Daxi and make a big splash and that wave never came to fruition. This is well known to injectors who have had multiple reps in a short time.